www.fdanews.com/articles/177291-cormatrix-earns-ce-mark-approval-for-cangaroo
CorMatrix Earns CE Mark Approval for CanGaroo
June 28, 2016
CorMatrix Cardiovascular has won CE mark approval for its CorMatrix CanGaroo extracellular matrix envelope, the Roswell, Ga.-based company announced Tuesday.
The device is designed for use with cardiac implantable electronic devices, such as pacemakers and implantable cardioverter defibrillators.
CanGaroo nabbed FDA clearance in August 2014. — Anisa Jibrell